WIPO International PCT Patents Portfolio 2026

DeepTech Innovation in Every Layer of Industrial & SieTech Intelligence

From PCT Patents to Global Industrial Deployment. Standalone Sponsorship-to-SPV Framework delivering Nobel-Level Scientific Validation without Core IP Dilution.

Become a Strategic Sponsor (+16% Yield) Explore 4 PCT Domain Pillars
Ecosystem Alignment & Validation Network
Siemens Xcelerator
Pecuria GmbH
ETH Zürich / CERN Standards
WIPO PCT
ZIM & Horizon Europe

Portfolio Architecture

4 WIPO PCT Technologies — One Strategic Investment Program

Independent validation, standalone SPV commercialization, and cross-domain industrial scaling.

01 PCT/IB2026/054397

Fabrics & Systems OS

POLx°IMAT Cross-System Operational OS (HCMOL) for industrial automation and decision intelligence.

  • Decision Intelligence (REGSI)
  • PLC, SCADA, Sensor Integration
  • Smart Fabrics & Materials
Base Sponsorship Target
€1,000,000
02 PCT/IB2026/060386+060541

Smart Pipe Infrastructure

Adaptive biomimetic pipeline infrastructure and high-precision dynamic locking mechanisms.

  • Adaptive Fluid Dynamics
  • Spherical Dynamic Locking
  • Water, Gas & Energy Pilot
Base Sponsorship Target
€1,000,000
03 PCT/IB2026/061333

Space Solar & Optics

Coordinated optical power transfer system and controlled laser energy beam conduits.

  • Beam Control & Receiver Nodes
  • Orbital Interface Prototypes
  • Space & Defense Dual-Use
Base Sponsorship Target
€1,500,000
04 NOBEL-LEVEL POTENTIAL

BioPOLx°IMAT Diagnostics

Biotechnology, biosensors, early disease detection, and cellular modulation interface.

  • Early Biomarker Anomaly Detection
  • Cellular Rejuvenation Engine
  • Non-Invasive Medical Gadgets
Base Sponsorship Target
€1,000,000

Live Interactive Sandbox

Simulate POLx°IMAT Core Engines

Experience real-time interactive parameter simulations for smart pipeline dynamics, optical transmission, and biosensor analytics.

REAL-TIME CANVA SIMULATION: SMART PIPE INFRASTRUCTURE ACTIVE STREAM

Pressure & Dynamic Locking Controls

Adjust dynamic pressure and joint bend angles to verify adaptive biomimetic stress dispersion (PCT/IB2026/060386).

Fluid Pressure (Bar): 120 Bar
Spherical Joint Angle (°): 18°
Stress Absorption:99.4% Nominal
Locking Mechanism Status:LOCKED & SECURE
NON-DILUTIVE SPV FRAMEWORK

Bridge Sponsorship Structure for Nobel-Level Impact

We separate operational execution from parent-entity IP. Sponsors finance independent laboratory validation (ETH Zürich / CERN standards) while retaining guaranteed financial returns and priority licensing rights.

+16% Yield
Structured Financial Return
Fixed pre-market bridge loan yield option.
100% IP
Core Patent Sovereignty
Protected core PCT assets retained in parent entity.
  • Standalone SPV structure per technology domain
  • Exclusive B2B service offsets & commercial usage rights
  • Clear milestone-based release ahead of EU/ZIM grants

Interactive Sponsorship Yield Calculator

SPV MODEL
Sponsorship Amount (€): €1,000,000
Bridge Yield (+16%):
€160,000
Total Return Value:
€1,160,000
Included Sponsor Offsets & Rights:
Priority OEM licensing rights in target market
Co-founder / Lead Sponsor positioning
Direct integration into Siemens Xcelerator marketplace

Ecosystem Scaling

Seamless Multi-Channel Commercialization

Deploying validated technologies directly through established global industrial marketplaces and API pipelines.

Siemens Xcelerator

Direct digital marketplace listing for SaaS, HCMOL operational modules, and smart hardware integration (Applications 2026–2027).

Digital Marketplace Integration

Pecuria GmbH (Claw + Hermes)

Multi-agent API pipeline integration coordinating automated business workflows, CRM, and SME stage deployment.

API Pipeline Synchronization

OEM MedGadget Licensing

Direct licensing of BioPOLx°IMAT non-invasive diagnostic sensors to pharmaceutical and medical device manufacturers.

B2B Licensing Pathways
Elena Loseva

Elena Loseva

Founder & CEO | LosVIT Industry POLx°IMAT Robotics
Patent Owner & DeepTech Strategist

"Bridging Fundamental Science with Industrial Scalability"

With the BioPOLx°IMAT and POLx°IMAT patent portfolio, we have unlocked a mathematical and biological core capable of transforming four trillion-dollar sectors simultaneously. Our goal is to connect visionary bridge sponsors with rigorous independent validation to bring these inventions to market.

Contact Email: info@losv-it.com / info@polximat.com
Active Markets: DACH (Switzerland, Germany, Austria) & Global
Direct Email